Reference [3]
[3] O’Mathúna B et al. The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans. J Clin Psychopharmacol. 2008;28(5):523–529. DOI 10.1097/JCP.0b013e318184ff6e. Human pharmacokinetic study; abstract and selected full-text methods, results and discussion checked for this proposed revision. Bibliographic pages: 523–529; the publisher PDF is printed as 525–531. Open publication
Source metadata
Abstract and selected full-text analysis, results and discussion checked in the recorded MDMA source package. Bibliographic pages: 523–529; the publisher PDF is printed as 525–531.
- Title
- The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans
- Authors
- O’Mathúna B
- Year
- 2008
- DOI
- 10.1097/JCP.0b013e318184ff6e
- PMID
- 18794647
- Accessed
- 2026-10-16
Where this source is cited
- 5. Serotonergic substances and stimulants
- MAOIs and MDMA
- Persistent interactions after subjective effects have ended